These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1370568)

  • 1. Vasoactive therapy versus placebo in the treatment of sudden hearing loss: a double-blind clinical study.
    Kronenberg J; Almagor M; Bendet E; Kushnir D
    Laryngoscope; 1992 Jan; 102(1):65-8. PubMed ID: 1370568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled study of dextran/pentoxifylline medication in acute acoustic trauma and sudden hearing loss.
    Probst R; Tschopp K; Lüdin E; Kellerhals B; Podvinec M; Pfaltz CR
    Acta Otolaryngol; 1992; 112(3):435-43. PubMed ID: 1279928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diatrizoate and dextran treatment of sudden sensorineural hearing loss.
    Redleaf MI; Bauer CA; Gantz BJ; Hoffman HT; McCabe BF
    Am J Otol; 1995 May; 16(3):295-303. PubMed ID: 8588622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of idiopathic sudden sensorineural hearing loss using pulse therapy: a prospective, randomized, double-blind clinical trial.
    Westerlaken BO; de Kleine E; van der Laan B; Albers F
    Laryngoscope; 2007 Apr; 117(4):684-90. PubMed ID: 17415139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Randomized double-blind study of therapy of sudden deafness. Low molecular weight dextran + naftidrofuryl vs. low molecular weight dextran + placebo].
    Poser R; Hirche H
    HNO; 1992 Oct; 40(10):396-9. PubMed ID: 1385372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.
    Wu HP; Chou YF; Yu SH; Wang CP; Hsu CJ; Chen PR
    Otol Neurotol; 2011 Jul; 32(5):774-9. PubMed ID: 21646929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recovery of hearing: results of delayed medical treatment in patients with idiopathic sudden hearing loss].
    Maassen MM; Pfister M; Plontke S; Koitschev A; Vögler A; Löwenheim H
    HNO; 2002 Dec; 50(12):1062-7. PubMed ID: 12474128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.
    Plontke SK; Löwenheim H; Mertens J; Engel C; Meisner C; Weidner A; Zimmermann R; Preyer S; Koitschev A; Zenner HP
    Laryngoscope; 2009 Feb; 119(2):359-69. PubMed ID: 19172627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Low molecular weight dextrans (Rheomacrodex) in the therapy of inner ear hearing loss].
    Erlach A; Rinke E
    Wien Med Wochenschr; 1986 Sep; 136(18):473-6. PubMed ID: 2432732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sudden sensorineural hearing loss: Is antiviral treatment really necessary?
    Övet G; Alataş N; Kocacan FN; Gürcüoğlu SS; Görgülü H; Güzelkara F; Övet H
    Am J Otolaryngol; 2015; 36(4):542-6. PubMed ID: 25749542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of systemic high-dose dexamethasone therapy for idiopathic sudden sensorineural hearing loss.
    Egli Gallo D; Khojasteh E; Gloor M; Hegemann SC
    Audiol Neurootol; 2013; 18(3):161-70. PubMed ID: 23446332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy of acute inner ear hearing loss in childhood and adolescence].
    Ptok M; Klein R; Ptok A; Berg PA; Zenner HP
    HNO; 1994 Oct; 42(10):636-42. PubMed ID: 7528187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroids, carbogen or placebo for sudden hearing loss: a prospective double-blind study.
    Cinamon U; Bendet E; Kronenberg J
    Eur Arch Otorhinolaryngol; 2001 Nov; 258(9):477-80. PubMed ID: 11769996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prostaglandin E1 on idiopathic sudden sensorineural hearing loss: a double-blinded clinical study.
    Ogawa K; Takei S; Inoue Y; Kanzaki J
    Otol Neurotol; 2002 Sep; 23(5):665-8. PubMed ID: 12218617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised, double-blinded, placebo-controlled, clinical trial of ozone therapy as treatment of sudden sensorineural hearing loss.
    Ragab A; Shreef E; Behiry E; Zalat S; Noaman M
    J Laryngol Otol; 2009 Jan; 123(1):54-60. PubMed ID: 18925995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratympanic steroid therapy in moderate sudden hearing loss: a randomized, triple-blind, placebo-controlled trial.
    Filipo R; Attanasio G; Russo FY; Viccaro M; Mancini P; Covelli E
    Laryngoscope; 2013 Mar; 123(3):774-8. PubMed ID: 23378346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: randomized triple-blind placebo-controlled trial.
    Nosrati-Zarenoe R; Hultcrantz E
    Otol Neurotol; 2012 Jun; 33(4):523-31. PubMed ID: 22429944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratympanic steroid injection as a first-line therapy in uremia patients with sudden sensorineural hearing loss.
    Tsai HT; Hsueh N; Huang CM; Lin HC
    Acta Otolaryngol; 2015 Aug; 135(8):786-90. PubMed ID: 25783847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic sudden sensorineural hearing loss: prognostic factors.
    Xenellis J; Karapatsas I; Papadimitriou N; Nikolopoulos T; Maragoudakis P; Tzagkaroulakis M; Ferekidis E
    J Laryngol Otol; 2006 Sep; 120(9):718-24. PubMed ID: 16854244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.